Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of €134.64 billion as of November 28, 2025. Its market cap has increased by 21.49% in one year.

Market Cap

134.64B

Enterprise Value

147.03B

Revenue

24.79B

Ranking

n/a

PE Ratio

19.48

Stock Price

€107.94

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 134.64B, an increase of 69,133.26%. That is a compound annual growth rate of 21.30%.

Market Cap History

Date	Market Cap	% Change
Nov 28, 2025	134.64B	21.09%
Dec 31, 2024	111.19B	21.76%
Dec 29, 2023	91.32B	-9.36%
Dec 30, 2022	100.75B	25.80%
Dec 31, 2021	80.09B	34.14%
Dec 31, 2020	59.70B	-18.50%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	50.35B
Siemens Healthineers AG	47.80B
Bayer Aktiengesellschaft	30.08B
Fresenius SE & Co. KGaA	26.67B
Sartorius Aktiengesellschaft	15.09B
Fresenius Medical Care AG	11.88B
Carl Zeiss Meditec AG	3.90B
Fielmann Group AG	3.67B

Market Cap Rankings